ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.

Ying-Chun Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.